1,3-Benzodioxolyl-N-methylpentanamine

MBDP
Clinical data
Other names1,3-Benzodioxolyl-N-methylpentanamine; N-Methyl-1,3-benzodioxolylpentanamine; MBDP; 3,4-Methylenedioxy-α-propyl-N-methylphenethylamine; Methyl-K; UWA-091; UWA091
Routes of
administration
Oral
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-methylpentan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H19NO2
Molar mass221.300 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(NC)CCC)OCO2
  • InChI=1S/C13H19NO2/c1-3-4-11(14-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3
  • Key:PZVRSDBLMSXDCX-UHFFFAOYSA-N

MBDP, also known as N-methyl-1,3-benzodioxolylpentanamine, 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, methyl-K, or UWA-091, is a psychoactive drug of the phenethylamine, phenylisobutylamine, and MDxx families. It is the N-methyl analogue of BDP (K).

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MBDP's minimum dose as 100 mg orally and its duration as unknown. The drug produced no effects at tested doses.

Chemistry

Synthesis

The chemical synthesis of MBDP has been described.

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.

See also